TCEB2 antibody

Catalogue No.:FNab08549Reactivity:Human
Host:RabbitTested Application:ELISA, WB, IHC, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
TCEB2 antibody
Catalogue No.
FNab08549
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
UniProt ID
Q15370
Observed MW
16 kDa
Application
Tested Applications
ELISA, WB, IHC, IP
Recommended dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:200; IP: 1:20 - 1:50
Validated Images
HeLa cells were subjected to SDS PAGE followed by western blot with FNab08549(TCEB2 antibody) at dilution of 1:1000
IP Result of anti-TCEB2 (IP:FNab08549, 4ug; Detection:FNab08549 1:500) with HEK-293 cells lysate 3200ug.
Immunohistochemistry of paraffin-embedded human colon cancer using FNab08549(TCEB2 antibody) at dilution of 1:100
Background
This gene encodes the protein elongin B, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. Pseudogenes have been identified on chromosomes 11 and 13.